Ra Capital Management, L.P. - Former 10% Owner at iTeos Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Former 10% Owner
Stock Symbol
ITOS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Ra Capital Management, L.P. - trading volume in the past year for iTeos Therapeutics, Inc.

Holdings reported by Ra Capital Management, L.P. for iTeos Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Pre- Funded Warrants (Right to Buy) 6.61 M $116 M $17.50 May 12, 2024 Indirect Common Stock
Common Stock 2.55 M $21.3 M $8.37 May 12, 2024 Indirect

Transactions reported by Ra Capital Management, L.P. for iTeos Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership